Effect of sclerostin inactivation in a mouse model of severe dominant osteogenesis imperfecta
Abstract Osteogenesis imperfecta (OI) is a rare bone disease that is associated with fractures and low bone mass. Sclerostin inhibition is being evaluated as a potential approach to increase bone mass in OI. We had previously found that in Col1a1 Jrt/+ mice, a model of severe OI, treatment with an a...
Main Authors: | Juliana Marulanda, Josephine T. Tauer, Iris Boraschi-Diaz, Ghalib Bardai, Frank Rauch |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32221-3 |
Similar Items
-
Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta
by: Pierre Moffatt, et al.
Published: (2021-05-01) -
Bladder and bowel symptoms experienced by children with osteogenesis imperfecta
by: Gisele Martins, et al.
Published: (2020-07-01) -
Bladder and bowel symptoms experienced by children with osteogenesis imperfecta
by: Gisele Martins, et al.
Published: (2020-07-01) -
Evaluation of the Severity of Malocclusion in Children with Osteogenesis Imperfecta
by: Manuel Joaquín De Nova-García, et al.
Published: (2022-08-01) -
Influence of the Severity of Osteogenesis Imperfecta on Cranial Measurements
by: Manuel Joaquín De Nova-García, et al.
Published: (2023-06-01)